Kelly Financial Services’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-150
| Closed | -$6K | – | 147 |
|
|
2024
Q2 | $6K | Hold |
150
| – | – | ﹤0.01% | 477 |
|
|
2024
Q1 | $6.59K | Hold |
150
| – | – | ﹤0.01% | 471 |
|
|
2023
Q4 | $9.28K | Hold |
150
| – | – | ﹤0.01% | 409 |
|
|
2023
Q3 | $6.9K | Hold |
150
| – | – | ﹤0.01% | 420 |
|
|
2023
Q2 | $8.62K | Hold |
150
| – | – | ﹤0.01% | 381 |
|
|
2023
Q1 | $5.63K | Hold |
150
| – | – | ﹤0.01% | 414 |
|
|
2022
Q4 | $4.2K | Hold |
150
| – | – | ﹤0.01% | 423 |
|
|
2022
Q3 | $4.22K | Hold |
150
| – | – | ﹤0.01% | 417 |
|
|
2022
Q2 | $5.22K | Hold |
150
| – | – | ﹤0.01% | 396 |
|
|
2022
Q1 | $5.39K | Hold |
150
| – | – | ﹤0.01% | 420 |
|
|
2021
Q4 | $3.49K | Hold |
150
| – | – | ﹤0.01% | 485 |
|
|
2021
Q3 | $2.85K | Sell |
150
-2,874
| -95% | -$54.6K | ﹤0.01% | 479 |
|
|
2021
Q2 | $150K | Buy |
3,024
+2,874
| +1,916% | +$143K | 0.01% | 324 |
|
|
2021
Q1 | $2.75K | Hold |
150
| – | – | ﹤0.01% | 474 |
|
|
2020
Q4 | $3.02K | Hold |
150
| – | – | ﹤0.01% | 425 |
|
|
2020
Q3 | $2.81K | Hold |
150
| – | – | ﹤0.01% | 401 |
|
|
2020
Q2 | $3.37K | Hold |
150
| – | – | ﹤0.01% | 378 |
|
|
2020
Q1 | $2.23K | Hold |
150
| – | – | ﹤0.01% | 378 |
|
|
2019
Q4 | $2.89K | Hold |
150
| – | – | ﹤0.01% | 368 |
|
|
2019
Q3 | $2.98K | Hold |
150
| – | – | ﹤0.01% | 358 |
|
|
2019
Q2 | $3.17K | Hold |
150
| – | – | ﹤0.01% | 339 |
|
|
2019
Q1 | $3.07K | Buy |
+150
| New | +$3.07K | ﹤0.01% | 341 |
|